EMVision Medical Devices Ltd (ASX:EMV)

Market Cap	162.64M +3.9%
Revenue (ttm)	5.05M -55.0%
Net Income	-9.81M
EPS	-0.11
Shares Out	92.94M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	46,921
Average Volume	44,636
Open	1.775
Previous Close	1.810
Day's Range	1.735 - 1.790
52-Week Range	1.630 - 2.430
Beta	1.04
RSI	41.31
Earnings Date	Feb 26, 2026

About EMVision Medical Devices

EMVision Medical Devices Ltd engages in the research, development, and commercialization of neurodiagnostic technology for stroke diagnosis and monitoring, and other medical imaging needs in Australia. It offers non-invasive brain scanners, including emu Brain Scanner, a bedside device; and First Responder Brain Scanner, a device embedded in standard road and air ambulances to deliver pre-hospital stroke diagnosis and care to patients. The company was incorporated in 2017 and is based in Macquarie Park, Australia.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2017
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: EMV

Financial Performance

In fiscal year 2025, EMVision Medical Devices's revenue was 5.05 million, a decrease of -54.97% compared to the previous year's 11.22 million. Losses were -9.81 million, 259.2% more than in 2024.